Stock PHGE.U BIOMX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. BiomX Inc. Nyse

Equities

PHGE.U

US09090D2027

Delayed Nyse
Other stock markets
 21:15:01 05/07/2024 BST 		5-day change 1st Jan Change
0.4 USD 0.00% Intraday chart for BiomX Inc. 0.00% +58.73%
05-21 Transcript : BiomX Inc., Q1 2024 Earnings Call, May 21, 2024
05-20 BiomX Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Cuts Price Target on BiomX to $7 From $10, Maintains Buy Rating
MT
Chardan Lowers Price Target on BiomX to $2 From $6, Keeps Buy Rating
MT
Chardan Lowers BiomX's Price Target to $6 From $10, Maintains Buy Rating
MT
Ladenburg Thalmann Lowers BiomX's Price Target to $8 From $13, Maintains Buy Rating
MT
Chardan Research Trims Price Target on BiomX to $12 From $13; Buy Rating Kept
MT
Chardan Research Trims Price Target on BiomX to $13 From $16; Buy Rating Kept
MT
BIOMX : Chardan Adjusts Price Target on BiomX to $16 From $28 After "Disappointing" Drug Trial Results, Maintains Buy Rating
MT
BIOMX : HC Wainwright Adjusts BiomX Price Target to $10 From $20, Maintains Buy Rating
MT
BIOMX : Ladenburg Thalmann Initiates BiomX at Buy With $25 Price Target
MT
BIOMX : HC Wainwright Starts BiomX at Buy With $20 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHGE Stock
  4. PHGE.U Stock
  5. News BiomX Inc.
  6. Analyst Reco.